U.S. Markets open in 9 hrs 24 mins

Regeneron Pharma Earnings, Revenue Beat in Q2

Regeneron Pharma Earnings, Revenue Beat in Q2

Investing.com - Regeneron Pharma reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.

The firm reported earnings per share of $6.02 on revenue of $1.93B. Analysts polled by Investing.com anticipated EPS of $5.37 on revenue of $1.8B. That compared to EPS of $5.45 on revenue of $1.61B in the same period a year earlier. The company had reported EPS of $4.45 on revenue of $1.71B in the previous quarter.


Regeneron Pharma follows other major Healthcare sector earnings this month

On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.

Merck&Co earnings beat analysts' expectations on July 30, with second quarter EPS of $1.3 on revenue of $11.76B. Investing.com analysts expected EPS of $1.16 on revenue of $10.96B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Henry Schein Earnings Beat, Revenue Misses In Q2

Diabetes drug maker Novo Nordisk buys pill factory in North Carolina

Duke Energy Earnings, Revenue Beat in Q2